2018 Global Cryptosporidium Testing Market – Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

DUBLIN–(BUSINESS WIRE)–The “2018
Global Cryptosporidium Testing Market: US, Europe, Japan – Sales Segment
Forecasts by Country, Competitive Intelligence, Emerging Technologies,
Instrumentation and Opportunities”
report has been added to ResearchAndMarkets.com’s
offering.

The report presents a detailed analysis of the Cryptosporidium
diagnostics market in the US, Europe, (France, Germany, Italy, Spain,
UK) and Japan. Current scientific views on the Cryptosporidium
definition, epidemiology and etiology are reviewed. The report provides
the 5-year test volume and sales forecasts by country for the following
market segments:

  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Also, the report examines the market applications of DNA Probes,
Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles
leading suppliers and recent market entrants developing innovative
technologies and products; and identifies emerging business expansion
opportunities, alternative market penetration strategies, market entry
barriers and risks, and strategic planning issues and concerns.

Companies Featured

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreat

For more information about this report visit https://www.researchandmarkets.com/research/jfjpc2/2018_global?w=4

الموقع يستعمل RSS Poster بدعم القاهرة اليوم